Clinical Trial Update: A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial update for DS9051b in advanced or metastatic adrenocortical carcinoma and metastatic castration-resistant prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Castration-resistant Prostate Cancer

Drugs mentioned

• DS9051b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced or Metastatic Adrenocortical Carcinoma, Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: RECRUITING